150 related articles for article (PubMed ID: 34667584)
1. NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery.
García-García A; Hicks T; El Qaidi S; Zhu C; Hardwidge PR; Angulo J; Hurtado-Guerrero R
Chem Sci; 2021 Sep; 12(36):12181-12191. PubMed ID: 34667584
[TBL] [Abstract][Full Text] [Related]
2. NleB/SseK effectors from
El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
[TBL] [Abstract][Full Text] [Related]
3. YM155 Inhibits NleB and SseK Arginine Glycosyltransferase Activity.
Zhu C; El Qaidi S; McDonald P; Roy A; Hardwidge PR
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33672424
[TBL] [Abstract][Full Text] [Related]
4. Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.
Koh E; Kim U; Cho HS
Sci Rep; 2022 Nov; 12(1):19288. PubMed ID: 36369343
[TBL] [Abstract][Full Text] [Related]
5. Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity.
Araujo-Garrido JL; Bernal-Bayard J; Ramos-Morales F
Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32131463
[TBL] [Abstract][Full Text] [Related]
6. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
[TBL] [Abstract][Full Text] [Related]
7. Bacteria-Catalyzed Arginine Glycosylation in Pathogens and Host.
Pan X; Luo J; Li S
Front Cell Infect Microbiol; 2020; 10():185. PubMed ID: 32411621
[TBL] [Abstract][Full Text] [Related]
8. Auto Arginine-GlcNAcylation Is Crucial for Bacterial Pathogens in Regulating Host Cell Death.
Xue J; Pan X; Peng T; Duan M; Du L; Zhuang X; Cai X; Yi X; Fu Y; Li S
Front Cell Infect Microbiol; 2020; 10():197. PubMed ID: 32432056
[TBL] [Abstract][Full Text] [Related]
9. Arg-GlcNAcylation on TRADD by NleB and SseK1 Is Crucial for Bacterial Pathogenesis.
Xue J; Hu S; Huang Y; Zhang Q; Yi X; Pan X; Li S
Front Cell Dev Biol; 2020; 8():641. PubMed ID: 32766249
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for arginine glycosylation of host substrates by bacterial effector proteins.
Park JB; Kim YH; Yoo Y; Kim J; Jun SH; Cho JW; El Qaidi S; Walpole S; Monaco S; García-García AA; Wu M; Hays MP; Hurtado-Guerrero R; Angulo J; Hardwidge PR; Shin JS; Cho HS
Nat Commun; 2018 Oct; 9(1):4283. PubMed ID: 30327479
[TBL] [Abstract][Full Text] [Related]
11. SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages.
Günster RA; Matthews SA; Holden DW; Thurston TLM
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069818
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Avasimibe to Inhibit Bacterial Glycosyltransferases.
Hasan MK; El Qaidi S; McDonald P; Roy A; Hardwidge PR
Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335693
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.
El Qaidi S; Zhu C; McDonald P; Roy A; Maity PK; Rane D; Perera C; Hardwidge PR
Front Cell Infect Microbiol; 2018; 8():435. PubMed ID: 30619781
[TBL] [Abstract][Full Text] [Related]
14. An intra-bacterial activity for a T3SS effector.
El Qaidi S; Scott NE; Hays MP; Geisbrecht BV; Watkins S; Hardwidge PR
Sci Rep; 2020 Jan; 10(1):1073. PubMed ID: 31974499
[TBL] [Abstract][Full Text] [Related]
15.
Newson JPM; Scott NE; Yeuk Wah Chung I; Wong Fok Lung T; Giogha C; Gan J; Wang N; Strugnell RA; Brown NF; Cygler M; Pearson JS; Hartland EL
Mol Cell Proteomics; 2019 Jun; 18(6):1138-1156. PubMed ID: 30902834
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the glycosyltransferase activity of the
Esposito D; Günster RA; Martino L; El Omari K; Wagner A; Thurston TLM; Rittinger K
J Biol Chem; 2018 Apr; 293(14):5064-5078. PubMed ID: 29449376
[TBL] [Abstract][Full Text] [Related]
17. Structural insights showing how arginine is able to be glycosylated by pathogenic effector proteins.
Park JB; Yoo Y; Cho HS
BMB Rep; 2018 Dec; 51(12):609-610. PubMed ID: 30463645
[TBL] [Abstract][Full Text] [Related]
18. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL
PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469
[TBL] [Abstract][Full Text] [Related]
19. Arginine glycosylation enhances methylglyoxal detoxification.
El Qaidi S; Scott NE; Hardwidge PR
Sci Rep; 2021 Feb; 11(1):3834. PubMed ID: 33589708
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
